Camdiclox-LB Capsule
Amoxicillin 250 mg + Cloxacillin 250 mg + Lactobacillus 2 Billion Spores Capsules
| Composition | Amoxicillin 250 mg + Cloxacillin 250 mg + Lactobacillus 2 Billion Spores |
|---|---|
| Dosage Form | Capsule |
| Pack Type | Blister |
| Pack Size | 10 x 10 Capsules |
| MRP | ₹ 980 |
| Therapy | G.P. + Orthopaedics + Gynaecology + Dental + ENT — Aminopenicillin + Penicillinase-Resistant Penicillin + Probiotic |
| Storage | Store below 30 °C in a dry place, protected from light and moisture. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Camdiclox-LB Capsule
Camdiclox-LB Capsule combines Amoxicillin 250 mg with Cloxacillin 250 mg and Lactobacillus 2 Billion spores. The combination provides broad-spectrum activity against both penicillinase-producing (typically staphylococci) and non-producing bacteria, with concurrent probiotic protection against antibiotic-associated diarrhoea.
Cloxacillin is a beta-lactamase-resistant penicillin specifically active against penicillinase-producing Staphylococcus aureus (MSSA). Adding Cloxacillin to Amoxicillin extends antibacterial coverage to staphylococcal infections that would otherwise destroy Amoxicillin’s beta-lactam ring. The combination is widely used for skin/soft-tissue infections, surgical site infections and ENT infections where mixed flora is likely.
Camdiclox-LB is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing.
Indications
- Skin and soft-tissue infections (cellulitis, impetigo, boils)
- Surgical site infections and post-operative prophylaxis
- ENT infections with mixed flora
- Dental infections with staphylococcal component
- Bone and joint infections (adjunct)
- Mastitis
Mechanism of Action
Amoxicillin inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins. Cloxacillin's bulky isoxazolyl side-chain sterically prevents penicillinase-mediated hydrolysis, retaining activity against MSSA. Lactobacillus competes with pathogenic gut flora and reduces antibiotic-associated diarrhoea.
Dosage & Administration
Adults: 1 capsule three times daily for 5–7 days; longer for severe infections. Take 1 hour before or 2 hours after meals.
Side Effects
Mild GI upset, nausea, diarrhoea (reduced by Lactobacillus). Rare: hypersensitivity, anaphylaxis, pseudomembranous colitis.
Contraindications & Precautions
Hypersensitivity to penicillins, cephalosporins or any beta-lactam. Infectious mononucleosis. Severe acute pancreatitis.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
Camdiclox-LB Capsule is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Camdiclox-LB Capsule used for?
Camdiclox-LB combines Amoxicillin, Cloxacillin and Lactobacillus for skin, soft-tissue, surgical, ENT and dental infections — particularly where penicillinase-producing staphylococci are suspected.
Why combine Amoxicillin with Cloxacillin?
Cloxacillin is beta-lactamase-resistant and active against penicillinase-producing Staphylococcus aureus. Combining it with Amoxicillin extends coverage to staphylococcal infections that would otherwise inactivate Amoxicillin.
Is Camdiclox-LB available for PCD pharma franchise?
Yes, on monopoly-based PCD pharma franchise and third-party manufacturing.
How should Camdiclox-LB be stored?
Store below 30 °C in a dry place, protected from light and moisture.
Is Camdiclox-LB WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Amoxirut-500 LB Capsule — Amoxicillin 500 mg + Lactobacillus 60 Million Spores
- Amoxirut-250 LB Capsule — Amoxicillin 250 mg + Lactobacillus 1.66 Billion Spores
- Amrocip-500 Tablet — Ciprofloxacin Hydrochloride 500 mg